Abstract
The present invention relates to a combination comprising at least four antimicrobial agents selected from rifampicin, levofloxacin, polymyxin E, polymyxin B, doxycycline, ceftazidime, and pharmaceutically acceptable derivatives thereof. Also provided is the combination for use in the treatment of a bacterial infection.
| Original language | English |
|---|---|
| Patent number | WO2024062236 |
| IPC | A61P 31/04 2006.1,A61K 31/396 2006.1 |
| Publication status | Published - 20 Sept 2023 |